Company Monitoring Page for Roche

latest headlines for company on cafepharma

Roche stays mum about FTC, CMA reviews as $4.3B Spark deal faces yet another delay. What's up?
Endpoints
Tue, 09/3/19 - 10:56 am
Tags:
Roche, Spark Therapeutics, FTC, CMA, M&A
Roche’s Xofluza limits spread of flu virus, says new study
Pharmaforum
Mon, 09/2/19 - 12:09 pm
Tags:
Roche, Xofluza, clinical trials, influenza
Novartis takes aim at Roche's star MS drug
Reuters
Fri, 08/30/19 - 10:08 am
Tags:
Novartis, Roche, multiple sclerosis, Arzerra, ofatumumab, Ocrevus
Does competition equal lower prices? MS drugs defied cost logic as challengers swarmed in
Fierce Pharma
Thu, 08/29/19 - 08:18 pm
Tags:
multiple sclerosis, MS, drug pricing, Biogen, Roche, Sanofi, Novartis, Teva Pharmaceutical, Bayer
EMA follows FDA to approve Roche's Tecentriq combo for frontline use in triple negative breast cancer
Endpoints
Thu, 08/29/19 - 12:26 pm
Tags:
Roche, Tecentriq, FDA, Europe, Celgene, Abraxane, triple negative breast cancer
Mark Your Calendar For These September PDUFA Dates
Yahoo/Benzinga
Wed, 08/28/19 - 12:53 pm
Tags:
FDA, Roche, Celgene, Tecentriq, Xeris Pharmaceuticals, Gvoke, Ardelyx, tenapanor, Merck, Pifeltro, Delstrigo, Novo Nordisk, semaglutide, JNJ, Genmab, daratumumab, Invokana
Amgen biosimilar debut boosted by UnitedHealthcare coverage switch
Biopharma Dive
Mon, 08/19/19 - 11:52 am
Tags:
insurers, Amgen, biosimilars, Avastin, Herceptin, Roche, UnitedHealthcare
Roche cancer treatment priced at $17,050 a month, lower than rival Vitrakvi
Reuters
Sat, 08/17/19 - 12:08 am
Tags:
Roche, Rozlytrek, Bayer, Eli Lilly, personalized medicine
Four New Drugs are Around the Corner. Here’s What You Need to Know.
Xconomy
Thu, 08/15/19 - 11:39 pm
Tags:
FDA, drug approvals, AbbVie, Upadacitinib, Exondys 51, Sarepta Therapeutics, Nabriva Therapeutics, lefamulin, Roche, Rozlytrek
Roche scores double cancer approval for new Bayer rival Rozlytrek
Fierce Pharma
Thu, 08/15/19 - 11:32 pm
Tags:
Roche, Rozlytrek, FDA, NTRK fusion-positive tumors, non-small cell lung cancer
Roche Expands Global Access to Viral Assays to Aid Eradication Efforts
Medical Devices and Diagnostics Industry
Fri, 08/9/19 - 07:42 pm
Tags:
Roche, viral assays, HIV, HPV, diagnostics, Global Access Program
Roche says test showed Tecentriq helped vs bladder cancer
Reuters
Mon, 08/5/19 - 11:03 am
Tags:
Roche, Tecentriq, bladder cancer
Thrashed by a 'surprise' rival, Sanofi writes off $2B on soured hemophilia deal
Endpoints
Mon, 07/29/19 - 09:39 am
Tags:
Sanofi, earnings, Roche, Hemlibra, hemophilia, Eloctate
Go or no go? Abbvie, Roche and Kala await key decisions
EP Vantage
Fri, 07/26/19 - 11:04 am
Tags:
FDA, AbbVie, upadacatinib, Roche, Ignyta, entrectinib, Kala Pharmaceuticals, KPI-121, dry eye disease
Roche (RHHBY) 1H19 Earnings & Sales Up Y/Y, View Raised
Yahoo/Zacks.com
Thu, 07/25/19 - 10:37 am
Tags:
Roche, earnings
Roche axes early-phase inflammatory disease drug
Fierce Biotech
Thu, 07/25/19 - 10:31 am
Tags:
Roche, RG6174, R&D, inflammatory diseases
Roche, like Bayer, was hit in Winnti cyberattack
Fierce Pharma
Wed, 07/24/19 - 10:14 am
Tags:
Bayer, Roche, hacking, cyberattack, cybersecruity
Roche cuts loose Tamiflu OTC rights, handing Sanofi the keys as the pharma giant doubles down on Xofluza
Endpoints
Tue, 07/23/19 - 12:04 pm
Tags:
Roche, Tamiflu, OTC, Xofluza, Sanofi
Roche doomsday is here: Long-feared Herceptin, Avastin biosims bust into U.S. market
Fierce Pharma
Fri, 07/19/19 - 07:28 pm
Tags:
Herceptin, Avastin, Roche, biosimilars, Allergan, Amgen
Roche and Novo Nordisk Top Clinical Trial Transparency Survey
BioSpace
Fri, 07/19/19 - 10:46 am
Tags:
Roche, Novo Nordisk, JNJ, clinical trials, clinical trial transparency

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.